Efficacy and Safety of Peptide Receptor Radionuclide Therapy in Lung Neuroendocrine Tumors: A Multicenter Study

被引：0
|
作者：
Iravani, A. [1 ,2 ]
Zidan, L. [1 ]
Oleinikov, K. [3 ]
Ben-Haim, S. [4 ]
Gross, D. [3 ]
Meirovitz, A. [5 ]
Maimon, O. [5 ]
Akhurst, T. [1 ]
Michael, M. [6 ]
Hicks, R. [1 ]
Grozinsky-Glasberg, S. [3 ]
Kong, G. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, ENETS Ctr Excellence, Mol Imaging & Therapeut Nucl Med, Melbourne, Vic, Australia
[2] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA
[3] Hadassah Hebrew Univ Med Ctr, Neuroendocrine Tumor Unit, ENETS Ctr Excellence, Dept Endocrinol, Jerusalem, Israel
[4] Hadassah Hebrew Univ Med Ctr, Nucl Med, Jerusalem, Israel
[5] Hadassah Hebrew Univ Med Ctr, Sharett Inst Oncol, Jerusalem, Israel
[6] Peter MacCallum Canc Ctr, Med Oncol, ENETS Ctr Excellence, Melbourne, Vic, Australia
来源：
PANCREAS | 2021年 / 50卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
C-21
引用
收藏
页码：451 / 451
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience
    Sukrithan, Vineeth
    Armbruster, Heather
    Rogers, Sherise
    Vogt, Sherry Mori
    Grenade, Cassandra
    Verschraegen, Claire
    Zhou, Ye
    Goyal, Ashima
    Natwa, Mona
    Hussein, Akram
    Barr, Hallie
    Konate, Dramane
    Batdorf, Rochelle
    Brown, Andrew
    Williams, Bonnie
    Zhao, Songzhu
    Wei, Lai
    Xu, Menglin
    Shah, Manisha H.
    Konda, Bhavana
    PLOS ONE, 2024, 19 (05):
  • [2] Safety and Efficacy of Peptide Receptor Radionuclide Therapy after Liver Transplantation in Metastatic Neuroendocrine Tumors
    Kulkarni, H.
    Kaemmerer, D.
    Hoersch, D.
    Hommann, M.
    Baum, R. P.
    NEUROENDOCRINOLOGY, 2012, 96 : 42 - 43
  • [3] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
    Bodei, Lisa
    Kidd, Mark
    Prasad, Vikas
    Modlin, Irvin M.
    NEUROENDOCRINE TUMORS: A MULTIDISCIPLINARY APPROACH, 2015, 44 : 198 - 215
  • [4] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
    Basu, Sandip
    Parghane, Rahul, V
    Kamaldeep
    Chakrabarty, Sudipta
    SEMINARS IN NUCLEAR MEDICINE, 2020, 50 (05) : 447 - 464
  • [5] Peptide receptor radionuclide therapy of neuroendocrine tumors
    Haug, A. R.
    Bartenstein, P.
    ONKOLOGE, 2011, 17 (07): : 602 - +
  • [6] Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of life
    Severi, Stefano
    Grassi, Ilaria
    Nicolini, Silvia
    Sansovini, Maddalena
    Bongiovanni, Alberto
    Paganelli, Giovanni
    ONCOTARGETS AND THERAPY, 2017, 10 : 551 - 557
  • [7] Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors
    Alayli, Adam
    Ngo, Hoang
    Sikaria, Dhiraj
    Ahmed, Altan
    Salloum, Elias
    Strosberg, Jonathan R.
    Al-Toubah, Taymeyah E.
    Kis, Bela
    Haider, Mintallah
    El-Haddad, Ghassan
    CANCERS, 2024, 16 (15)
  • [8] Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors
    Bodei, Lisa
    Cremonesi, Marta
    Kidd, Mark
    Grana, Chiara M.
    Severi, Stefano
    Modlin, Irvin M.
    Paganelli, Giovanni
    THORACIC SURGERY CLINICS, 2014, 24 (03) : 333 - +
  • [9] Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
    Kwekkeboom, Dik J.
    Krenning, Eric P.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (01) : 179 - +
  • [10] Safety and efficacy of peptide receptor radionuclide therapy in treating high-risk patients with extensive neuroendocrine tumors
    Alsadik, S. R.
    Gnanasegaran, G.
    Chen, L.
    Toumpanakis, C.
    Caplin, M.
    Navalkissoor, S.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 172 - 172
12345